Prostate cancer screening: Continued controversies and novel biomarker advancements

Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and public health. Despite being the second most common cancer in men worldwide, recommendations for screening using prostate-specific antigen (PSA) are unclear. Early detection and the resulting postscreening t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tidd-Johnson, Atiyah, Sebastian, Sneha Annie, Co, Edzel Lorraine, Afaq, Munaza, Kochhar, Hansini, Sheikh, Mona, Mago, Arpit, Poudel, Sujan, Fernandez, John A., Rodriguez, Ivan D., Razdan, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Special Topic: Advances in Prostate Cancer Therapy: Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875204/
https://www.ncbi.nlm.nih.gov/pubmed/36714234
http://dx.doi.org/10.1097/CU9.0000000000000145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875204/
https://www.ncbi.nlm.nih.gov/pubmed/36714234
http://dx.doi.org/10.1097/CU9.0000000000000145

Ejemplares similares